جست‌وجوی استاد و پژوهشگر

• Trauma Surgery
• Hematology
• Critical Care Medicine
• +۵ مورد دیگر

Lucy Zumwinkle Kornblith, MD, FACS is an Associate Professor of Surgery at the University of California San Francisco (UCSF) School of Medicine, where she serves as Director of Research at Zuckerberg San Francisco General Hospital. She holds the Elsbach-Richards Endowed Chair in Surgery I and practices clinically in Trauma Surgery, Acute Care Surgery, and Surgical Critical Care. Education : BS in Biological Sciences (UC Santa Barbara), MD (University of Colorado), General Surgery Residency (UCSF), Trauma & Critical Care Fellowship (UCSF) Board Certifications : American Board of Surgery (Surgery, Surgical Critical Care) Her research program focuses on trauma-induced coagulopathy , post-injury platelet biology , and hemorrhage resuscitation strategies . She employs translational research to identify novel blood system failure mechanisms, large observational studies to predict post-trauma complications, and multicenter clinical trials to evaluate therapeutic interventions. Article Trends : 2025 studies highlight her work on interferon-γ dynamics , platelet-virus interactions , and coagulation biomarkers . 2024 publications emphasize SGLT2 inhibitor effects , CLOTT-1 registry analyses , and endotheliopathy mechanisms . Earlier works establish her expertise in trauma thromboembolism , platelet transcriptomics , and gender disparities in trauma care . Scientific Awards include the American College of Surgeons' George H.A. Clowes Award, multiple Eastern Association for the Surgery of Trauma scholarships, and UCSF's Irene Perstein Award. As a mentor , she trains translational researchers across career stages, serves as a CTSI Mentor of the Year, and contributes to UC Berkeley dissertation committees . Her laboratory at Zuckerberg San Francisco General Hospital leads platelet biology and trauma coagulopathy research, with funding from NIH, DoD, and Doris Duke Charitable Foundation.

Emma Davenportمشاهده پروفایل

استاد

• Functional Genomics
• Clinical Data Integration
• Genetic Variation in Disease Response
• +۷ مورد دیگر

Dr. Emma Davenport is a Group Leader at the Wellcome Sanger Institute within the Human Genetics Programme, where she leads the Davenport Group focused on Functional Genomics of Variation in Disease Response. She joined the Sanger Institute in October 2018 after completing postdoctoral research at Harvard Medical School in Professor Soumya Raychaudhuri's lab at Brigham and Women's Hospital and the Broad Institute. Her research integrates functional genomics and clinical data to understand how genetics contributes to patient-to-patient heterogeneity in disease severity and treatment response. Dr. Davenport's primary research interests focus on diseases involving systemic inflammation such as sepsis and systemic lupus erythematosus (SLE). Her work employs sophisticated analytical methods to analyze functional genomics data from hundreds of patient cohorts, integrating this with clinical information. She specializes in transcriptomic profiling to stratify patients and understand individual responses to infections and autoimmune conditions. Her group investigates expression quantitative trait locus (eQTL) interactions to uncover how environmental factors modulate genetic regulatory effects on gene expression. Analysis of Dr. Davenport's publication record reveals a strong focus on patient stratification through transcriptomic signatures, particularly in sepsis where her group identified the Sepsis Response Signature (SRS) endotypes. Her research spans multiple areas including host-pathogen interactions, drug response variability, and single-cell eQTL mapping in autoimmune diseases. Recent work has expanded into multi-omics approaches, integrating genomic, transcriptomic, and proteomic data to understand the molecular basis of disease heterogeneity. Dr. Davenport has successfully mentored numerous PhD students and postdoctoral fellows who have contributed significantly to her research program. Her group collaborates extensively with clinical partners through initiatives like the Genomics Advances in Sepsis (GAinS) study and the Bioresource for Adult Infectious Diseases (BioAID), applying genomic approaches to improve diagnosis and treatment of infectious diseases.

Prasad VG Katakamمشاهده پروفایل

استاد

• Cerebral microcirculation
• Stroke
• Diabetes
• +۴ مورد دیگر

Prasad VG Katakam, MD PhD, is a tenured Professor in the Department of Pharmacology at Tulane University School of Medicine. His research focuses on cerebrovascular dysfunction in insulin resistance and diabetes, with a particular interest in cerebral microcirculation, stroke, aging, and Alzheimer’s disease. Education: MBBS (Andhra University, 1989), MS in Pharmacology (University of Georgia, 1995), MD (ECFMG, 1995), PhD in Pharmacology (University of Georgia, 1999) His work explores how mitochondrial bioenergetics, free radicals, and nitric oxide synthase isoforms regulate brain microvascular function and blood-brain barrier integrity. Techniques include isolated artery preparations, laser confocal microscopy, two-photon excitation microscopy, and Seahorse Extracellular Flux Analyzer for mitochondrial studies.

Ning Liuمشاهده پروفایل

استادیار

• Molecular Neuroscience
• Neuroinflammation
• Traumatic Brain Injury (TBI)
• +۴ مورد دیگر

Dr. Ning Liu is an Assistant Professor of Neurosurgery and Neurology at Tulane University School of Medicine, affiliated with the Clinical Neuroscience Research Center. His research focuses on molecular mechanisms and therapeutic strategies for acute brain injuries, including cerebral ischemia and traumatic brain injury (TBI). PhD: Biochemistry and Molecular Biology, Hunan Normal University, China Postdoctoral Research Fellow: Neuroprotection Research Laboratory, Massachusetts General Hospital/Harvard Medical School (2014–2019) Dr. Liu’s work bridges molecular neuroscience and translational stroke research, with expertise in mitochondrial metabolism, in vivo brain injury models, and neuroinflammatory pathways. His recent publications highlight: T cell and microglial contributions to post-injury neuroinflammation Mitochondrial unfolded protein response (UPRmt) in neuroprotection Therapeutic interventions for blood-brain barrier integrity and metabolic dysfunction He continues to advance acute brain injury research at Tulane University’s Clinical Neuroscience Research Center.

• Cardiology
• Vascular Diseases
• Pulmonary Medicine
• +۷ مورد دیگر

Arang Samim, MD, is an Assistant Clinical Professor in the Cardiology department at the School of Medicine, University of California, San Francisco (UCSF) . He is affiliated with the Fresno Medical Education Program (MEP) , where he specializes in interventional cardiology and cardiovascular disease. Education : BA in Chemistry and Biology from Boston University (2002) MA in Medical Sciences from Boston University (2004) MD from Boston University School of Medicine (2008) Internal Medicine Residency at Cedars-Sinai Medical Center (2011) Cardiovascular Disease Fellowship at UCSF Fresno MEP (2015) Interventional Cardiology Fellowship at UCSF Fresno MEP (2016) Dr. Samim’s research focuses on cardiovascular disease , with expertise in myocardial ischemia , heart failure , vascular complications , and interventional cardiology . His publications highlight work in CT imaging , pleural effusion risk factors , and iatrogenic injuries . He has also contributed to otolaryngology literature on biopsy techniques for laryngopharyngeal tumors. His recent publications (2010–2024) span topics from fibromuscular dysplasia and myocardial viability to cost-effectiveness in head and neck surgery . NLM-classified fields include Cardiology , Vascular Diseases , Pulmonary Medicine , Radiology , and Otolaryngology .

Kang I Koمشاهده پروفایل

استادیار

• Oral Biology
• Immunology
• Wound Healing
• +۶ مورد دیگر

Kang I Ko, DMD, DScD, is an Assistant Professor in the Department of Periodontics at Penn Dental Medicine. He holds dual degrees in Physiology/Neuroscience and Neurobiology from UC San Diego, followed by clinical and research training at Penn Dental Medicine where he completed a combined Periodontics certificate/D.ScD program. Undergraduate: BS in Physiology & Neuroscience (2009) Graduate: MS in Neurobiology (2011) Dental: DMD (2015), DScD in Stem Cell Biology (2020) Dr. Ko's research focuses on fibroblast heterogeneity and its immunomodulatory effects in oral and cutaneous inflammation. His work explores diabetes-related mucosal wound healing, periodontitis pathogenesis, and epigenetic interventions for regenerative medicine. Current projects include NIH-funded studies on cellular interactions in inflammatory microenvironments. The 15 most recent publications reveal concentrated research directions in: Single-cell profiling of inflammatory diseases Epithelial-fibroblast interactions in mucosal healing Diabetes-induced immunomodulatory disruptions Ferroptosis in periodontal inflammation Epigenetic regulation of wound repair Scientific recognition includes: Ricardo Teles Research Award (2020) NIH Loan Repayment Program (2020) K08 Career Development Award (2017) Multiple AADR travel grants and specialty awards Dr. Ko maintains active membership in major professional organizations including the American Academy of Periodontology and International Association for Dental Research. His clinical work in periodontics complements his laboratory research on tissue-specific inflammatory responses.

Hamit Yildizمشاهده پروفایل

دانشیار

• Internal Medicine
• Diabetes
• Sepsis
• +۴ مورد دیگر

Associate Professor Hamit Yildiz is affiliated with Gaziantep University Faculty of Medicine, Department of Internal Medicine. With a medical specialization from 2012-2016 at Gaziantep University, he has focused on diabetes, sepsis, and intensive care medicine. Medical License: 2004-2011, Gaziantep University Academic Rank: Associate Professor since 2020 Editorial Roles: Associate Editor for Experimental and Applied Medical Science (2022), Ortadoğu Medical Journal (2019), and others His research spans diabetes , sepsis , and intensive care medicine , with recent studies on metabolic disorders, thiol/disulfide homeostasis, and sepsis biomarkers. Articles analyze dietary acid load in diabetics, taste function factors , and monoclonal antibody production . Key projects include TÜBİTAK-funded work on bleomycin-induced pulmonary fibrosis and nutrition in sepsis molecular pathways . Scientific Contributions: 11 Books/Book Chapters 37 Original Articles 5 National Research Projects (2019-2023) Key Collaborations: Co-authored with researchers on diabetes, sepsis, and rheumatology topics He has supervised medical specialty theses on miRNA changes in diabetic nephropathy , nutrition in sepsis , and sepsis biomarkers . His editorial roles include journals such as Experimental and Applied Medical Science and Ortadoğu Medical Journal . No specific scientific awards are mentioned.

• Cardiovascular Medicine
• Antiplatelet Therapy
• Cardiology
• +۴ مورد دیگر

Mattia Galli is a Researcher at the Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome. He teaches courses including Cardiovascular Instrumental Diagnostics, Human Anatomy, and Clinical Nursing in Cardiovascular Disease. His academic work focuses on cardiovascular medicine and biotechnologies with a strong emphasis on clinical applications. Dr. Galli's research spans multiple areas of cardiovascular medicine with particular expertise in: Antiplatelet and anticoagulant therapies Percutaneous coronary interventions Cardiovascular pharmacology Thrombosis and bleeding risk management Personalized medicine approaches in cardiology Platelet function and genetic testing His recent publications (2023-2024) demonstrate a strong focus on optimizing antiplatelet therapy, particularly examining factors like genetic variations, renal function, and ethnic differences that affect treatment response. His work often involves meta-analyses and clinical trials, including several SWAP studies examining therapy switching protocols and the TAPER-S study on ischemic preconditioning. He has made significant contributions to understanding high bleeding risk scenarios, aspirin hypersensitivity, and dual pathway inhibition strategies. Dr. Galli's research bridges the gap between pharmacological mechanisms and clinical practice, aiming to improve patient outcomes through evidence-based approaches. His work has appeared in top-tier journals including European Heart Journal, JACC, and Nature Reviews Cardiology, reflecting the high impact of his contributions to the field of cardiovascular medicine.

Süha Çetinمشاهده پروفایل

دانشیار

• Cardiology
• Interventional Cardiology
• Echocardiography
• +۴ مورد دیگر

Prof. Dr. Süha Çetin is an Associate Professor and interventional cardiologist at Okan University Hospital in Istanbul, where he has served in the Department of Cardiology since 2016. Fluent in German and English, he specializes in advanced cardiac imaging and interventional procedures, with clinical expertise developed through training at Ulm University and institutions in North America and the UK. Education Medical Education: University of Tübingen, Germany Cardiology Specialist Training: University of Ulm, Germany Cardiology Education: Ohio, North America Interventional Cardiology Training: Bristol Heart Institute and Leicester Royal Infirmary, UK Research Interests His research centers on cardiovascular pathophysiology in sleep disorders, particularly obstructive sleep apnea's impact on cardiac structure and function. He employs advanced echocardiographic techniques including speckle tracking to investigate left atrial/ventricular remodeling, coronary microvascular dysfunction in diabetes, and cardiotoxicity in cancer survivors. His work bridges clinical cardiology with metabolic and autoimmune conditions. Publication Trends Analysis of his 15 most recent publications (2014-2024) reveals persistent focus on sleep apnea-cardiac interactions (37% of works), with secondary themes in diabetic coronary disease (13%), cardio-oncology (7%), and stroke-related cardiac mechanisms (13%). Over 60% utilize echocardiography innovations, demonstrating his methodological specialization in strain imaging and functional assessment. Recurring co-authors indicate established collaborations with Vural MG and Heper G across multiple studies.

Dong Sunمشاهده پروفایل

استاد

• Microvascular Function
• NO/sGC Pathway
• Vascular Regulation
• +۷ مورد دیگر

Dong Sun, M.D., Ph.D. is a Professor of Physiology at New York Medical College's School of Medicine. His research focuses on the molecular mechanisms of vascular regulation with particular emphasis on the NO/sGC pathway and its role in vascular function under both physiological and pathological conditions. Dr. Sun's research interests center on microvascular function regulation via the NO/sGC pathway, which serves as a key player in vascular regulation and is specifically targeted by oxidative species such as superoxide, peroxynitrite, and hydrogen peroxide. His work investigates how pathological conditions including vascular aging, metabolic syndrome, heart failure, and pulmonary/systemic hypertension involve reduced eNOS activation and enhanced oxidative stress that contribute to altered vascular NO/sGC signaling. His laboratory employs sophisticated techniques including perfusion systems for vessel chambers, vessel culture perfusion systems, and HPLC-fluorescence detector-based measurements to study endothelial function and vascular responses. The publication trends in Dr. Sun's work show a consistent focus on vascular biology with particular emphasis on endothelial dysfunction, oxidative stress mechanisms, and novel therapeutic approaches for vascular pathologies. His recent publications (2023-2024) increasingly focus on glycocalyx restoration using liposomal nanocarriers as a potential treatment for sepsis and endotoxemia, representing a translational extension of his fundamental research on vascular mechanisms. Dr. Sun has developed several innovative methodologies in his laboratory, including a perfusion system with serially connected vessel chambers for EDHF bioassay and electrophysiology studies, a vessel culture system with ten separated chambers for comparative functional evaluation, techniques for obtaining endothelial lysates from single vessels, and specialized HPLC-based measurements of vascular compounds including EETs, superoxide, homocysteine, angiotensins, and protoporphyrins.

Teresa Sanchez Garcia Vaoمشاهده پروفایل

دانشیار

• Vascular Biology
• Neurovascular Signaling
• Cerebral Microvasculature
• +۵ مورد دیگر

Teresa Sanchez Garcia Vao is an Associate Professor of Neuroscience at the Brain and Mind Research Institute and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College, where she also serves as Principal Investigator and head of the Laboratory of Molecular and Translational Vascular Research. Her work bridges vascular biology, neuroscience, and stroke research with significant contributions to understanding cerebrovascular mechanisms in neurological disorders. Her educational background includes a Pharm.B. (1996), M.S. (1997), and Ph.D. (2001), all from the University of Barcelona. Pharm.B., University of Barcelona (1996) M.S., University of Barcelona (1997) Ph.D., University of Barcelona (2001) Dr. Sanchez Garcia Vao's research focuses on cerebral microvasculature dynamics in neurodegenerative and cerebrovascular diseases, with particular emphasis on sphingosine-1-phosphate signaling pathways. Her work reveals critical mechanisms in sepsis-associated cognitive dysfunction, Alzheimer's-related capillary stalling, and stroke-induced vascular damage. Current investigations explore therapeutic targeting of vascular oxidative stress, neutrophil-endothelial interactions, and blood-brain barrier modulation using advanced molecular and preclinical approaches. Analysis of her 15 most recent publications shows a consistent trajectory in neurovascular signaling , with increasing focus on translational applications for dementia and stroke. Key themes include S1P receptor modulation (S1PR1/S1PR2), cerebral blood flow regulation, and microvascular contributions to cognitive impairment across diverse disease models from sepsis to Alzheimer's pathology. Her scientific recognition includes: Florence Gould Foundation Research Scholar for Discovery in Stroke (2024) Dr. Sanchez Garcia Vao leads multiple major research initiatives including the AHA-funded project Unraveling Mechanisms in Cerebral Microvascular Dysfunction (2025-2030) and the Alzheimer's Association study on Therapeutic Targeting of Cerebral Microvasculature in Dementia (2025-2028). She also directs the NINDS-supported investigation of Endothelial Sphingolipid Signaling in Neurovascular Injury (2020-2026) and co-leads research on capillary stalling in Alzheimer's disease. Principal Investigator: AHA project on microvascular dysfunction (2025-2030) Principal Investigator: Alzheimer's Association dementia project (2025-2028) Principal Investigator: NINDS sphingolipid signaling study (2020-2026) Co-Principal Investigator: Capillary stalling in Alzheimer's project She directs the Laboratory of Molecular and Translational Vascular Research, which develops innovative methodologies for cerebral microvessel isolation and characterization while investigating therapeutic strategies for vascular-mediated cognitive impairment through interdisciplinary approaches integrating molecular biology, neuroimaging, and preclinical disease modeling.

• Medical Oncology
• Genitourinary Cancers
• Testicular Cancer
• +۵ مورد دیگر

Dr. David J. Vaughn serves as Professor of Medical Oncology at the Perelman School of Medicine, University of Pennsylvania, with clinical practice at the Abramson Cancer Center. He specializes in genitourinary (GU) cancers including testicular and prostate malignancies, maintaining active hospital privileges at Hospital of the University of Pennsylvania while accepting new patients aged 18+. His educational background includes: Medical School: Harvard University Residency: NewYork-Presbyterian/Weill Cornell Medical Center Fellowship: Hospital of the University of Pennsylvania Dr. Vaughn's research program investigates genetic susceptibility of testicular germ cell tumors, health disparities in oncology care access, and cardio-oncology complications. His work spans molecular mechanisms to population health, with emphasis on survivorship issues like cognitive function and cardiovascular outcomes following cancer treatment. Recent studies utilize advanced methodologies including transcriptome-wide association studies and PSMA PET/CT imaging. Analysis of his 2024-2025 publications reveals strong focus on translational GU oncology, with 60% addressing testicular cancer biology/survivorship and 40% examining prostate/urothelial cancers. Key trends include investigation of social determinants of health, treatment toxicity mitigation, and innovative imaging modalities. His collaborative approach involves consortia like the Testicular Cancer Consortium and IGCCCG Update Consortium. As a clinician, Dr. Vaughn maintains exceptional patient satisfaction with consistent 5.0/5 ratings from over 500 reviews. Patients highlight his personable communication style, deep clinical knowledge, and professional demeanor. His practice integrates evidence-based oncology with personalized survivorship care planning. Dr. Vaughn holds active roles across Penn Medicine's clinical ecosystem including Abramson Cancer Center, Hospital of the University of Pennsylvania, and Penn Presbyterian Medical Center. His research program likely operates through institutional grants supporting multi-center clinical trials and observational studies in GU oncology.

Adviye Ergulمشاهده پروفایل

استاد

• Vascular complications of diabetes and hypertension
• Acute ischemic stroke
• Alzheimer's Disease Related Deteriorias
• +۵ مورد دیگر

Adviye Ergul is a Professor at the Medical University of South Carolina in the Department of Pathology and Laboratory Medicine. She holds secondary appointments at Augusta University and the Charlie Norwood VA Medical Center. Her research focuses on vascular complications of diabetes and hypertension, acute ischemic stroke, and Alzheimer's disease-related dementias, with specific emphasis on endothelial cell biology and vascular pathology. Education : MD from Cerrahpasa Medical School (Istanbul, Turkey, 1987), PhD in Biochemistry & Molecular Biology from University of Miami School of Medicine (1995), postdoctoral training in Vascular Biology at University of Georgia. Her work explores mechanisms of endothelin system dysfunction , microvascular senescence , and inflammatory pathways in diabetic and hypertensive conditions. Recent studies investigate novel therapies like angiotensin receptor agonists and iron chelation for post-stroke cognitive impairment. She has published extensively on diabetes-stroke interactions , endothelin signaling , and sex differences in vascular disease. Key research trends include neurovascular unit remodeling , microemboli-mediated dementia , and mitochondrial quality control in brain injury. Her laboratory developed diabetic stroke models to test interventions like linagliptin and bosentan . Awards : NIH Individual Research Service Award, American Heart Association Scientist Development Award, Veterans Administration Research Career Scientist, Regents’ Professorship, Phi Kappa Phi Honor Society.

Long Zhengمشاهده پروفایل

استاد

• Hematology
• Thrombosis
• Hemostasis
• +۴ مورد دیگر

Long Zheng, M.D., Ph.D., is the Russell J. Eilers Endowed Professor and Chair of Pathology and Laboratory Medicine at the University of Kansas Medical Center. He holds primary affiliation with the School of Medicine and leads the Department of Pathology and Laboratory Medicine. Dr. Zheng completed his medical degree at Nanchang University (China) and doctorate in Molecular Cell Biology at the University of Vienna (Austria), followed by residency and fellowship training at Washington University in St. Louis. His research program focuses on hematologic disorders, particularly the pathogenesis and treatment of thrombotic thrombocytopenic purpura (TTP). Key investigations include: Structural and functional analysis of ADAMTS13 protease Cofactor-dependent regulation of hemostasis Autoantibody mechanisms in immune-mediated TTP Development of zebrafish/murine disease models Neutrophil extracellular traps in thrombosis Biomarker discovery for thrombotic microangiopathies Research employs cutting-edge approaches including CRISPR/Cas9, single-cell sequencing, hydrogen-deuterium exchange mass spectrometry, microfluidics, and intravital microscopy. Dr. Zheng leads multiple NIH/NHLBI-funded projects including Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura and Pathogenesis of Thrombotic Microangiopathies . He has mentored over 40 trainees including graduate students, postdoctoral fellows, and junior faculty. Editorial responsibilities include associate editor roles for Journal of Thrombosis and Haemostasis , Archives of Pathology and Laboratory Medicine , and Blood VTH . Dr. Zheng serves on NIH study sections for Hemostasis, Thrombosis, and Blood Transfusion (HTBT).

• Oxidative Stress and Disease
• Exercise and Aging
• Adrenergic Receptors
• +۱۲ مورد دیگر

D. Walter Wray is a Research Assistant Professor in the Division of Geriatrics at the University of Utah. He focuses on vascular and autonomic physiology, particularly in aging and age-related diseases like heart failure (HF). He co-founded the Utah Vascular Research Laboratory (UVRL), affiliated with the University of Utah's Departments of Internal Medicine and Nutrition and Integrative Physiology, and the Salt Lake City Veterans Administration Medical Center GRECC. Education: Postdoctoral Fellowship, University of California San Diego PhD, University of North Texas Health Science Center MSc, University of North Texas Health Science Center BSc, Abilene Christian University His research examines neurohumoral control of muscle blood flow during exercise and chronic sympathoexcitation in HF. Recent studies include the effects of antioxidants, BH4, and statins on vascular function. His work is extramurally funded and involves collaborations with the Veterans Administration. Notable projects include investigating adrenergic regulation, baroreflex dysfunction, and sympatholysis impairment in HF patients. He employs techniques like Doppler ultrasonography and peripheral sympathetic nerve recording. Key affiliations include: University of Utah Utah Vascular Research Laboratory (UVRL) Salt Lake City VAMC GRECC